Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
Journal of Chemical Information and Modeling|March 17, 2023
Proteochemometric Modeling Identifies Chemically Diverse Norepinephrine Transporter InhibitorsBrandon J Bongers, Huub J Sijben, Peter B R Hartog, et al.
Biochemical Pharmacology|January 7, 2018
A binding kinetics study of human adenosine A3 receptor agonistsLizi Xia, Athina Kyrizaki, Dilip K Tosh, et al.
Scientific Reports|June 11, 2021
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitorsHubert J Sijben, Wieke M van Oostveen, Peter B R Hartog, et al.
European Journal of Medicinal Chemistry|April 29, 2021
Synthesis and SAR evaluation of coumarin derivatives as potent cannabinoid receptor agonistsFlorian Mohr, Thomas Hurrle, Lindsey Burggraaff, et al.
Journal of Medicinal Chemistry|March 15, 2019
Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A3 ReceptorXue Yang, Jacobus P D van Veldhoven, Jelle Offringa, et al.
Purinergic Signalling|July 9, 2023
Kinetic profiling of novel spirobenzo-oxazinepiperidinone derivatives as equilibrative nucleoside transporter 1 inhibitorsAnna Vlachodimou, Jara Bouma, Michel De Cleyn, et al.
Chembiochem : a European Journal of Chemical Biology|February 19, 2024
Discovery of a Photoaffinity Probe that Captures the Active Conformation of the Cannabinoid CB2 ReceptorLaura V De Paus, Yu An, Antonius P A Janssen, et al.
Molecular Pharmacology|July 28, 2017
A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding StudiesAndrea Martella, Huub Sijben, Arne C Rufer, et al.
European Journal of Pharmacology|October 31, 2024
The effect of cancer-associated mutations on ligand binding and receptor function - A case for the 5-HT2C receptorChenlin Feng, Rongfang Liu, Reno Brooks, et al.
Pageof 16